BioNTech to Host Second "AI Day" on October 1, 2025, as Part of "Innovation Series"

BioNTech, a global innovative immunotherapy company, is hosting its second "AI Day" on October 1, 2025, in London. The event will showcase the company's AI strategy and capabilities, highlighting the application of AI in their pipeline and internal processes. The event will be live-streamed and available on BioNTech's website. A recording and presentation will also be available for one year. BioNTech is a leader in developing therapies for cancer and other severe diseases, combining modern therapeutic platforms and bioinformatics tools.

BioNTech SE (NASDAQ: BNTX), a leading global biopharmaceutical company, has announced its second AI Day event, scheduled for October 1, 2025, at 9:00 AM EDT in London. The event, part of BioNTech's Innovation Series, will showcase the company's artificial intelligence (AI) strategy and capabilities, focusing on the application of AI in their pipeline and internal processes BioNTech to Host Second AI Day as an Edition of Its Innovation Series on October 1, 2025^[1].

The live webcast of the event will be accessible through a link provided on BioNTech's website, with slides and a recording available for one year following the event on the Investor Relations section of the company's website BioNTech to Host Second AI Day as an Edition of Its Innovation Series on October 1, 2025^[1]. This event marks a significant milestone in BioNTech's continued focus on AI development, following their acquisition of InstaDeep Ltd. BioNTech to Host Second AI Day as an Edition of Its Innovation Series on October 1, 2025^[1].

BioNTech, known for its innovative therapies for cancer and other serious diseases, combines modern therapeutic platforms and bioinformatics tools to develop novel biopharmaceuticals. The company's diversified portfolio includes mRNA cancer immunotherapies, next-generation immunomodulators, targeted therapies, and innovative chimeric antigen receptor (CAR) T cell therapies BioNTech to Host Second AI Day as an Edition of Its Innovation Series on October 1, 2025^[1].

BioNTech's AI strategy is part of its broader commitment to leveraging advanced technologies to accelerate drug discovery and development. The company's focus on AI-driven development and precision medicine underscores its leadership among biotech innovators. The event will provide insights into how BioNTech is utilizing AI to enhance its research and development processes, potentially leading to more efficient and effective therapies BioNTech to Host Second AI Day as an Edition of Its Innovation Series on October 1, 2025^[1].

The event comes at a time when BioNTech is making significant strides in its mRNA vaccine and specialty medicine portfolio. The company's collaboration with Pfizer Inc. (NYSE: PFE) on the COVID-19 vaccine has been particularly notable, and BioNTech continues to push the boundaries of mRNA technology Pfizer Inc. (PFE) Pushes Forward in Cancer and Hemophilia Treatments^[2].

The second AI Day event will be a valuable opportunity for investors and financial professionals to gain a deeper understanding of BioNTech's AI strategy and its potential impact on the company's future growth and innovation. The event will also provide a platform for BioNTech to showcase its ongoing research and development efforts, highlighting the company's commitment to using AI to drive progress in the biopharmaceutical industry BioNTech to Host Second AI Day as an Edition of Its Innovation Series on October 1, 2025^[1].